80 related articles for article (PubMed ID: 23341473)
1. Do former substance users with psychosis differ in their symptoms or function from non-substance users? A systematic meta-analysis.
Gupta P; Mullin K; Nielssen O; Harris A; Large M
Aust N Z J Psychiatry; 2013 Jun; 47(6):524-37. PubMed ID: 23341473
[TBL] [Abstract][Full Text] [Related]
2. Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use.
Large M; Mullin K; Gupta P; Harris A; Nielssen O
Aust N Z J Psychiatry; 2014 May; 48(5):418-32. PubMed ID: 24589980
[TBL] [Abstract][Full Text] [Related]
3. Does giving up substance use work for patients with psychosis? A systematic meta-analysis.
Mullin K; Gupta P; Compton MT; Nielssen O; Harris A; Large M
Aust N Z J Psychiatry; 2012 Sep; 46(9):826-39. PubMed ID: 22368242
[TBL] [Abstract][Full Text] [Related]
4. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
Iyer SN; Boekestyn L; Cassidy CM; King S; Joober R; Malla AK
Psychol Med; 2008 Aug; 38(8):1147-56. PubMed ID: 18366823
[TBL] [Abstract][Full Text] [Related]
5. Depression and quality of life in first-episode psychosis.
Renwick L; Jackson D; Foley S; Owens E; Ramperti N; Behan C; Anwar M; Kinsella A; Turner N; Clarke M; O'Callaghan E
Compr Psychiatry; 2012 Jul; 53(5):451-5. PubMed ID: 21871616
[TBL] [Abstract][Full Text] [Related]
6. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
Møller T; Linaker OM
Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
[TBL] [Abstract][Full Text] [Related]
7. Substance use and psychotic-like experiences in young people: a systematic review and meta-analysis.
Matheson SL; Laurie M; Laurens KR
Psychol Med; 2023 Jan; 53(2):305-319. PubMed ID: 36377500
[TBL] [Abstract][Full Text] [Related]
8. Effect of substance misuse in early psychosis.
Addington J; Addington D
Br J Psychiatry Suppl; 1998; 172(33):134-6. PubMed ID: 9764140
[TBL] [Abstract][Full Text] [Related]
9. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
10. The relationship between depressive symptoms and negative symptoms in people with non-affective psychosis: a meta-analysis.
Edwards CJ; Garety P; Hardy A
Psychol Med; 2019 Nov; 49(15):2486-2498. PubMed ID: 31530319
[TBL] [Abstract][Full Text] [Related]
11. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.
Leeson VC; Harrison I; Ron MA; Barnes TR; Joyce EM
Schizophr Bull; 2012 Jun; 38(4):873-80. PubMed ID: 21389110
[TBL] [Abstract][Full Text] [Related]
12. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
13. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
14. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
[TBL] [Abstract][Full Text] [Related]
15. Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis.
Myles N; Newall HD; Curtis J; Nielssen O; Shiers D; Large M
J Clin Psychiatry; 2012 Apr; 73(4):468-75. PubMed ID: 22579146
[TBL] [Abstract][Full Text] [Related]
16. Depression and depressive symptoms in first episode psychosis.
Romm KL; Rossberg JI; Berg AO; Barrett EA; Faerden A; Agartz I; Andreassen OA; Melle I
J Nerv Ment Dis; 2010 Jan; 198(1):67-71. PubMed ID: 20061872
[TBL] [Abstract][Full Text] [Related]
17. Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms.
Kamali M; McTigue O; Whitty P; Gervin M; Clarke M; Browne S; Larkin C; O'Callaghan E
Early Interv Psychiatry; 2009 Aug; 3(3):198-203. PubMed ID: 22640383
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.
Weibell MA; Hegelstad WTV; Auestad B; Bramness J; Evensen J; Haahr U; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan T; McGorry P; Friis S
Schizophr Bull; 2017 Jul; 43(4):843-851. PubMed ID: 28199703
[TBL] [Abstract][Full Text] [Related]
19. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
[TBL] [Abstract][Full Text] [Related]
20. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort.
Schimmelmann BG; Huber CG; Lambert M; Cotton S; McGorry PD; Conus P
J Psychiatr Res; 2008 Oct; 42(12):982-90. PubMed ID: 18199456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
